Olaparib CAS 763113-22-0 Product Guide
Table of Contents
- Product Specifications & Comparative Analysis
- Therapeutic Applications & Mechanism of Action
- Dosage & Administration Guidelines
- Clinical Efficacy Case Studies
- Industry User Testimonials
- Technical Consultation & Ordering
1. Product Specifications & Comparative Analysis
| Parameter | Olaparib CAS 763113-22-0 | Competitor A | Competitor B |
|---|---|---|---|
| Purity | ≥99.5% | ≥98.0% | ≥97.5% |
| Solubility | DMSO: 83 mg/mL | DMSO: 75 mg/mL | DMSO: 68 mg/mL |
| Storage | -20°C, 3 years | -15°C, 2 years | 4°C, 1 year |
2. Therapeutic Applications & Mechanism of Action
As a PARP (Poly ADP-ribose polymerase) inhibitor, Olaparib demonstrates exceptional performance in:
- Ovarian cancer maintenance therapy
- BRCA-mutated breast cancer treatment
- Prostate cancer with homologous recombination deficiency
- Pancreatic adenocarcinoma management
3. Dosage & Administration Guidelines
| Formulation | Recommended Dose | Frequency |
|---|---|---|
| Tablets (150mg) | 300mg | BID |
| Capsules (50mg) | 400mg | BID |
4. Clinical Efficacy Case Studies
Case 1: Advanced Ovarian Cancer Treatment
Patient Profile: 58-year-old female with BRCA1 mutation
Protocol: 300mg BID for 28-day cycles
Outcome: Progression-free survival extended by 13.6 months
Case 2: Metastatic Breast Cancer Management
Patient Profile: HER2-negative, HR-positive metastatic case
Protocol: Combination therapy with endocrine agents
Outcome: 62% reduction in tumor markers
5. Industry User Testimonials
Pharmaceutical Manufacturer A (EU-based):
“Consistent batch-to-batch purity exceeding 99.5% significantly improved our formulation stability.”
Research Hospital B (US-based):
“Superior solubility characteristics reduced our preclinical preparation time by 40% compared to alternatives.”
6. Technical Consultation & Ordering
Contact our oncology API specialists:
Email: info@vivalr.com
Tel: (86) 15866781826
Keywords: PARP inhibitor supplier, high-purity Olaparib, BRCA mutation therapy, ovarian cancer treatment API, pharmaceutical-grade CAS 763113-22-0
相关产品
Chemical Name: Ethyl Hexanoate
Synonyms: Ethyl caproate; Caproic acid ethyl ester; Ethyl butyl acetate; capronic ether; hexanoic acid ethyl ester
CAS No.: 123-66-0
Molecular Formula: C8H16O2
Molecular Weight: 144.21
Chemical Name: alpha-Hexylcinnamaldehyde
CAS No.: 101-86-0
Molecular Formula: C15H20O
Molecular Weight: 216.32
Appearance: Yellow Liquid
Chemical Name: D-Phenothrin
CAS No.: 26046-85-5
Molecular Formula: C23H26O3
Molecular Weight: 350.45
Appearance: Oil
Chemical Name: 3-Hydroxybutyric acid
CAS No.: 625-71-8
Molecular Formula: C4H8O3
Molecular Weight: 104.1
Appearance: White powder
Chemical Name: D-Phenothrin
CAS No.: 26046-85-5
Molecular Formula: C23H26O3
Molecular Weight: 350.45
Appearance: Oil
Common English name: 5-iodo-2,3-dihydropyridazin-3-one
CAS No.: 825633-94-1
Molecular formula: C4H3IN2O
Molecular weight: 221.98
Sample: Available
Chemical Name: Marbofloxacin
CAS No.: 115550-35-1
Molecular Formula: C17H19FN4O4
Molecular Weight: 362.36
Appearance: Red-Brown Crystal
Chemical Name: DL-4-Chlorophenylglycine
Cas No.: 6212-33-5
Molecular Fomula: C8H8ClNO2
Molecular Weight: 185.61
Chemical Name: Zinc citrate
Synonyms: Zinc citrate trihydrate
CAS No.: 546-46-3
Molecular Formula: C6H8O7Zn
Molecular Weight: 257.5
Appearance: White powder
Chemical Name: 1,5-Diphenylcarbazide
Synonyms: 1,5-Diphenylcarbohydrazide; 2,2’-diphenylcarbazide; Diphenylcartazide; sym-diphenylcarbazide
CAS No.: 140-22-7
Molecular Formula: C13H14N4O
Molecular Weight: 242.28
Chemical Name: 1-[9-ethyl-6-(4-fluoro-benzoyl)-9H-carbazol-3-yl]-ethanone
Cas No.: 876907-97-0
Molecular Fomula: C23H18FNO2
Molecular Weight: 359.39
Chemical Name: 1,1,2,2-Tetrachloroethane
Other Name: Tetrachlorethane
CAS No.: 79-34-5
Molecular Formula: C2H2Cl4
Molecular Weight: 167.85
Appearance: Liquid
评论
目前还没有评论。